Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: A systematic review

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Czarny, Matthew J ^a,b   Arthurs, Erin ^c   Coffie, Diana Frances ^d,e   Smith, Cheri ^f   Steele, Russell J ^c,g   Ziegelstein, Roy C ^h   Thombs, Brett D ^c,g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

^f JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ACUTE CORONARY SYNDROME; DEPRESSION; DRUG USE; EUROPE; HUMAN; METHODOLOGY; NORTH AMERICA; OUTCOME ASSESSMENT; PRESCRIPTION; PREVALENCE; REVIEW; SAMPLE SIZE; SELF REPORT; SYSTEMATIC REVIEW; AGED; DATA BASE; FEMALE; MALE; META ANALYSIS; STATISTICS;

ACUTE CORONARY SYNDROME; AGED; ANTIDEPRESSIVE AGENTS; DATABASES AS TOPIC; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; PREVALENCE;

EID: 81755172382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027671     Document Type: Review

References (69)

1. Rudisch B, Nemeroff CB, (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54: 227-240.
2. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, et al. (2006) Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 21: 30-38.
3. Rumsfeld JS, Ho PM, (2005) Depression and cardiovascular disease: a call for recognition. Circulation 111: 250-253.
4. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, et al. (2004) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66: 814-822.
5. Olfson M, Marcus SC, (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66: 848-856.
6. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, et al. The ESEMeD/MHEDEA 2000 investigators (2004) Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109: 55-64.
7. Glassman AH, Roose SP, Bigger JT Jr, (1993) The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 269: 2673-2675.
8. Murray JB, (2000) Cardiac disorders and antidepressant medications. J Psychol 134: 162-168.
9. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701-709.
10. O'Connor CM, Jiang W, Kuchibhatla M, Silva SG, Cuffe MS, et al. (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56: 692-699.
11. Taylor D, (2008) Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatr Scand 118: 434-442.
12. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté M-A, van Zyl LT, et al. (2007) Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. JAMA 297: 367-379.
13. Strik JJMH, Honig A, Lousberg R, Lousberg AHP, Cheriex EC, et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosom Med 62: 783-789.
14. Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, et al. (2009) Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther 86: 527-532.
15. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, et al. (2008) Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300: 2161-2171.
16. Dowlati Y, Herrmann N, Swardfager WL, Reim EK, Lanctôt KL, (2010) Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatry 55: 91-99.
17. Mazza M, Lotrionte M, Biondi-Zoccai G, Abbate A, Sheiban I, et al. (2010) Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. J Psychopharmacol 24: 1785-1792.
18. Delisle VC, Arthurs E, Ziegelstein RC, Thombs BD, (Epub ahead of print) A meta-analysis of selective serotonin reuptake inhibitors in acute coronary syndrome: cause for concern. J Psychopharmacol.
19. Andrade C, Sandarsh S, Chethan KB, Nagesh KS, (2010) Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and reconsideration of mechanisms. J Clin Psychiatry 71: 1565-1575.
20. Pacher P, Kecskemeti V, (2004) Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des 10: 2462-2475.
21. U.S. Food and Drug Administration. Celexa (citalopram hydrobromide): drug safety communication- abnormal heart rhythms associated with higher doses. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHuma nMedicalProducts/ucm269481.htm. Accessed September 6, 2011.
22. Tibold A, Feher G, Csejtei A, Tettinger A, Kiss I, (2007) Selective serotonin reuptake inhibitors may interfere with the antiplatelet effect of clopidogrel. Am J Cardiol 99: 1025-1026.
23. Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, et al. (2007) Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med 120: 525-530.
24. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, et al. (2008) Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 65: 1358-1367.
25. Fosbol EL, Gislason GH, Poulsen HE, Hansen ML, Folke F, et al. (2009) Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used. Circ Heart Fail 2: 582-590.
26. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, et al. (2009) Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 53: 950-958.
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology. JAMA 283: 2008-2012.
28. Benazon NR, Mamdani MM, Coyne JC, (2005) Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002. Psychosom Med 67: 916-920.
29. Higgins JPT, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
30. R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna. http://www.R-project.org/.
31. Viechtbauer W, (2010) Conducting meta-anlayses in R with the metafor package. J Stat Softw 36: August 2010.
32. Grunau GL, Ratner PA, Goldner EM, Sheps S, (2006) Is early- and late-onset depression after acute myocardial infarction associated with long-term survival in older adults? A population-based study. Can J Cardiol 22: 473-478.
33. Lesperance F, Frasure-Smith N, Juneau M, Theroux P, (2000) Depression and 1-year prognosis in unstable angina. Arch Intern Med 160: 1354-1360.
34. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC, (2008) Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol 101: 602-606.
35. Sauer WH, Berlin JA, Kimmel SE, (2001) Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104: 1894-1898.
36. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, et al. (2003) Depression and prognosis following hospital admission because of acute myocardial infarction. Can Med Assoc J 168: 547-552.
37. Grace SL, Abbey SE, Pinto R, Shnek ZM, Irvine J, et al. (2005) Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation. Psychosom Med 67: 52-58.
38. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, et al. (2003) History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 145: 493-499.
39. Frasure-Smith N, Lesperance F, (2008) Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 65: 62-71.
40. Corser W, Hanak M, Stommel M, Olomu A, Yang Z, et al. (2006) Association of cardiac drugs with depression after acute coronary syndrome. J Pharm Technol 22: 319-325.
41. Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, et al. (2006) Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 166: 876-883.
42. Grace SL, Leung YW, Stewart DE, (2008) A prospective examination of antidepressant use and its correlates in patients with acute coronary syndrome. Psychosomatics 49: 199-207.
43. Huffman JC, Smith FA, Blais MA, Beiser ME, Januzzi JL, et al. (2006) Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items. Heart 92: 1656-1660.
44. Zimmermann-Viehoff F, Orth-Gomer K, Wang HX, Deter HC, Merswolken M, et al. (2010) Depressive symptoms and heart rate variability in younger women after an acute coronary event. Eur J Cardiovasc Prev Rehabil 17: 509-513.
45. Monster TB, Johnsen SP, Olsen ML, McLaughlin JK, Sorensen HT, (2004) Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med 117: 732-737.
46. Dickens C, McGowan L, Percival C, Tomenson B, Cotter L, et al. (2007) Depression is a risk factor for mortality after myocardial infarction: fact or artifact? J Am Coll Cardiol 49: 1834-1840.
47. Kaptein KI, de Jonge P, van den Brink RH, Korf J, (2006) Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis. Psychosom Med 68: 662-668.
48. Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, et al. (2001) Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 141: 765-771.
49. Sorensen C, Brandes A, Hendricks O, Thrane J, Friis-Hasche E, et al. (2005) Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand 111: 116-124.
50. Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, et al. (2005) Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 150: 652-658.
51. Costa Dias C, Mateus PS, Mateus C, Bettencourt N, Santos L, et al. (2005) Acute coronary syndrome and depression. Rev Port Cardiol 24: 507-516.
52. Bhattacharyya MR, Perkins-Porras L, Whitehead DL, Steptoe A, (2007) Psychological and clinical predictors of return to work after acute coronary syndrome. Eur Heart J 28: 160-165.
53. Parker GB, Hilton TM, Walsh WF, Owen CA, Heruc GA, et al. (2008) Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol Psychiatry 64: 660-666.
54. Wong CK, Tang EW, Herbison P, Birmingham B, Barclay L, et al. (2008) Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack. Q J Med 101: 137-144.
55. Mojtabai R, Olfson M, (2011) Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Affairs 30: 1434-1442.
56. Gill JM, Klinkman MS, Chen YX, (2010) Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study. J Am Board Fam Med 23: 499-508.
57. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney RM, et al. (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62: 792-798.
58. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, et al. (2008) Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118: 1768-1775.
59. Blackwell B, Marley E, Price J, Taylor D, (1967) Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiatry 113: 349-365.
60. U.S. Preventive Services Task Force (2009) Screening for depression in adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151: 784-792.
61. Jureidini J, Tonkin A, Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 20: 623-632.
62. Spina E, Santoro V, D'Arrigo C, (2008) Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clin Ther 30: 1206-1227.
63. Stahl SM, Grady MM, Moret C, Briley M, (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10: 732-747.
64. Krantz DS, Whittaker KS, Francis JL, Rutledge T, Johnson BD, et al. (2009) Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study. Heart 95: 1901-1906.
65. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, et al. (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med 169: 2128-2139.
66. Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, et al. (2006) Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol 98: 42-47.
67. Haapea M, Miettunen J, Lindeman S, Joukamaa M, Koponen H, (2010) Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort. Int J Methods Psychiatr Res 19: 88-96.
68. Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, et al. (2004) A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 159: 308-317.
69. Kwon A, Bungay KM, Pei Y, Rogers WH, Wilson IB, et al. (2003) Antidepressant use: concordance between self-report and claims records. Med Care 41: 368-374.